Owens & Minor (NYSE:OMI) Given New $24.00 Price Target at Robert W. Baird

Owens & Minor (NYSE:OMI) had its price objective lowered by Robert W. Baird from $28.00 to $24.00 in a report released on Monday morning, Benzinga reports. Robert W. Baird currently has a neutral rating on the stock.

A number of other research firms also recently commented on OMI. Citigroup boosted their target price on shares of Owens & Minor from $24.00 to $28.00 and gave the stock a neutral rating in a report on Tuesday, April 30th. TheStreet raised Owens & Minor from a d+ rating to a c- rating in a report on Monday, March 4th. Barclays raised their price objective on Owens & Minor from $21.00 to $23.00 and gave the stock an equal weight rating in a research note on Wednesday, February 21st. UBS Group cut their target price on Owens & Minor from $28.00 to $26.00 and set a buy rating on the stock in a research report on Monday, January 29th. Finally, StockNews.com raised Owens & Minor from a hold rating to a buy rating in a report on Wednesday, February 21st. One analyst has rated the stock with a sell rating, seven have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of Hold and an average target price of $23.29.

Owens & Minor Stock Performance

OMI opened at $18.12 on Monday. The business has a 50 day moving average price of $25.00 and a two-hundred day moving average price of $21.53. The company has a debt-to-equity ratio of 2.17, a current ratio of 1.16 and a quick ratio of 0.56. The company has a market capitalization of $1.39 billion, a price-to-earnings ratio of -35.53, a price-to-earnings-growth ratio of 0.57 and a beta of 0.52. Owens & Minor has a 1-year low of $13.64 and a 1-year high of $28.35.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings data on Friday, May 3rd. The company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.02. The business had revenue of $2.61 billion during the quarter, compared to analyst estimates of $2.61 billion. Owens & Minor had a positive return on equity of 12.97% and a negative net margin of 0.37%. The company’s revenue was up 3.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.05 earnings per share. Research analysts predict that Owens & Minor will post 1.54 EPS for the current fiscal year.

Insider Activity

In other news, SVP Jonathan A. Leon sold 5,000 shares of Owens & Minor stock in a transaction on Monday, April 22nd. The stock was sold at an average price of $24.84, for a total transaction of $124,200.00. Following the transaction, the senior vice president now owns 84,673 shares in the company, valued at $2,103,277.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, SVP Jonathan A. Leon sold 5,000 shares of the firm’s stock in a transaction that occurred on Monday, April 22nd. The shares were sold at an average price of $24.84, for a total transaction of $124,200.00. Following the completion of the sale, the senior vice president now directly owns 84,673 shares in the company, valued at $2,103,277.32. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Michael Wayne Lowry sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $25.00, for a total transaction of $250,000.00. Following the completion of the transaction, the senior vice president now owns 71,654 shares in the company, valued at approximately $1,791,350. The disclosure for this sale can be found here. Corporate insiders own 2.62% of the company’s stock.

Institutional Trading of Owens & Minor

A number of institutional investors have recently bought and sold shares of the company. Riverview Trust Co purchased a new stake in shares of Owens & Minor during the 1st quarter worth about $25,000. DekaBank Deutsche Girozentrale acquired a new position in Owens & Minor in the third quarter worth approximately $29,000. Quest Partners LLC bought a new position in Owens & Minor during the fourth quarter valued at approximately $41,000. Hexagon Capital Partners LLC lifted its stake in Owens & Minor by 1,240.2% in the first quarter. Hexagon Capital Partners LLC now owns 1,568 shares of the company’s stock valued at $43,000 after acquiring an additional 1,451 shares during the last quarter. Finally, GAMMA Investing LLC increased its stake in shares of Owens & Minor by 52.1% during the 1st quarter. GAMMA Investing LLC now owns 1,644 shares of the company’s stock worth $46,000 after purchasing an additional 563 shares during the last quarter. Institutional investors and hedge funds own 98.04% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.